GlassScriptPhysician profile
Darren T West
NPI 1316086226
$205,813.75
in general payments reported to CMS, 2019-2025
42 companies · $76K in 2025
The $76K reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19K · 2022: $29K · 2023: $52K · 2024: $29K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Consulting Fee: $27K · Food and Beverage: $25K · Travel and Lodging: $11K · Honoraria: $7,975 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,697 · Education: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,703.00 |
| Consulting Fee | $27,383.00 |
| Food and Beverage | $24,968.50 |
| Travel and Lodging | $11,035.36 |
| Honoraria | $7,975.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,697.00 |
| Education | $380.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $57,715.53 | 2021-2025 | Aklief, Epsolay, Oracea |
| Sun Pharmaceutical Industries INC. | $49,527.95 | 2021-2025 | Levulan Kerastick, Ilumya, Winlevi |
| Pfizer INC. | $32,422.17 | 2021-2025 | |
| Organon LLC | $14,382.83 | 2021-2025 | Vtama, Hadlima |
| Incyte Corporation | $8,296.42 | 2021-2025 | Opzelura, Opzelura |
| Botanix Sb INC | $4,787.21 | 2025 | Sofdra |
| Leo Pharma INC. | $4,237.77 | 2021-2025 | Adbry, Anzupgo |
| Abbvie INC. | $3,850.63 | 2021-2025 | |
| Dermavant Sciences, INC. | $3,416.32 | 2022-2024 | Vtama |
| Verrica Pharmaceuticals INC. | $3,105.71 | 2024 | Ycanth |
| Ucb, INC. | $2,627.99 | 2021-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $2,531.02 | 2021-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $2,156.95 | 2021-2024 | Siliq, Targretin, Jublia |
| Journey Medical Corporation | $2,095.11 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $2,073.41 | 2023-2025 | Zoryve |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,802.13 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $1,787.69 | 2022-2025 | Otezla, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $1,595.00 | 2025 | |
| Genzyme Corporation | $1,361.74 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,229.04 | 2021-2025 | |
| Epi Health, LLC | $1,018.53 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $944.51 | 2021-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $930.87 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Almirall LLC | $320.16 | 2021-2025 | Klisyri, Seysara |
| Mayne Pharma Commercial LLC | $297.72 | 2021-2025 | |
| Medimetriks Pharmaceuticals, INC. | $250.00 | 2024 | Clindacin Etz, Neo-Synalar |
| Paratek Pharmaceuticals, INC. | $211.92 | 2021-2023 | Nuzyra |
| Lnhc, INC | $125.00 | 2025 | Zelsuvmi |
| Janssen Scientific Affairs, LLC | $123.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.74 | 2023-2024 | Spevigo |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Kyowa Kirin, INC. | $70.14 | 2022-2025 | Poteligeo |
| Revance Therapeutics, INC. | $62.70 | 2025 | Daxxify |
| Vyne Pharmaceuticals INC. | $52.56 | 2021 | |
| Nabriva Therapeutics, Plc | $40.84 | 2021-2022 | |
| Sandoz INC. | $36.41 | 2023-2024 | Hyrimoz |
| Krystal Biotech INC | $34.46 | 2024 | Vyjuvek |
| Fresenius Kabi USA, LLC | $29.79 | 2023 | |
| Genentech USA, INC. | $24.84 | 2022 | |
| Dermira, INC. | $24.15 | 2021 | |
| Merck Sharp & Dohme LLC | $23.97 | 2023 | Keytruda |
| Biofrontera INC. | $21.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darren West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.